The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: "The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis"

Sampayo-Cordeiro, Miguel; Miguel-Huguet, Bernat; Malfettone, Andrea; Pérez-García, José Manuel; Llombart-Cussac, Antonio; Cortés, Javier; Pardo, Almudena; Pérez López, Jordi.
Front. mol. biosci. ; : 690615, jun. 2021. graf, tab
Artigo em Inglês | Repositório BVS | ID: biblio-1418391

Documentos relacionados

  1. False Dichotomies and Health Policy Research Designs: Randomized Trials Are Not Always the Answer.
  2. Critical appraisal of nonrandomized studies-A review of recommended and commonly used tools.
  3. The quality of control groups in nonrandomized studies published in the Journal of Hand Surgery.
  4. Meta-analysis of couple therapy in non-randomized clinical trial studies: Individual and couple level outcomes.
  5. Quasi-experimental study designs series-paper 13: realizing the full potential of quasi-experiments for health research.
  6. Nosso sistema imune de cada dia e os agrotóxicos de hoje
  7. Combining individual patient data from randomized and non-randomized studies to predict real-world effectiveness of interventions.
  8. Case studies to explore the optimal use of randomized and nonrandomized studies in evidence syntheses that use GRADE.
  9. [Systematic review on safety of Salvianolate injection].
  10. Stress testing journals: a quasi-experimental study of rejection rates of a previously published paper.